We observed that in the glioma cell lines, U87MG, U138MG, and U373MG, overexpression of sFRP4 resulted in inhibition of viability and proliferation as measured by MTT and BrdU assays respectively (Figure S1A,B). This evidence concerns the gene SFRP4 and central nervous system cancer.